Fluoroquinolones are a type of antibiotic that is an important part of a physicians prescribing arsenal.  However, they do carry with them some serious side effects and according to a new study published...

On Sunday’s airing of the Outbreak News This Week Radio Show, we looked at the new fluoroquinolone antibiotic, Baxdela, which garnered FDA approval recently. Assistant Professor of Medicine,...

The Food and Drug Administration recently approved a new antibiotic into the arsenal for treating serious acute bacterial skin and skin structure infections (ABSSSI). Its called delafloxacin and goes by...

Melinta Therapeutics announced Monday that the U.S. Food and Drug Administration (FDA) has approved Baxdela™ (delafloxacin), indicated in adults for the treatment of acute bacterial skin and skin structure...

Approximately one in four (22.1%) adults prescribed an antibiotic in an outpatient setting (such as a doctor’s office) for community-acquired pneumonia does not respond to treatment, according to a new...

Melinta Therapeutics announced Monday that it has submitted New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for approval of IV and oral Baxdela™ (delafloxacin) for the treatment...